YO

Yossi Ohayon

Active Director Director DIN 08323433
DIN 08323433 First appointment Jun 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value •••• Premium profile

About Yossi Ohayon

Data last updated:

Yossi Ohayon is a Director at Bioline Implant Technologies Private Limited (since 2020). The company operates in Healthcare. Bioline Implant Technologies Private Limited reported revenue of ₹7.80 Cr (FY 2025).

DIN 08323433
Primary Designation Director
Industry Healthcare
First Appointment 01 Jun 2020
Oldest Company Age 6 yrs
Largest company Bioline Implant Technologies Private Limited · ₹7.80 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jun 20202019₹7.80 Cr (FY 2025)Active

Board colleagues of Yossi Ohayon

Directorship timeline

Open interactive timeline →
Bioline Implant Technologies Private Limited
Premium access

Shareholding and investment profile for Yossi Ohayon

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yossi Ohayon

Yossi Ohayon currently holds 1 directorship: Bioline Implant Technologies Private Limited (Director, since 01 Jun 2020, revenue ₹7.80 Cr (FY 2025)).

Yossi Ohayon was first appointed on 01 Jun 2020 as Director at Bioline Implant Technologies Private Limited.

The current boards of Yossi Ohayon's companies include Sanjeevareddy Vaddireddy Vijayabhaskar Reddy (Bioline Implant Technologies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available